搜索
Cartesian Therapeutics Inc
RNAC添加自选
10.590USD
+0.410+4.03%
收盘 07/02, 13:00（美东）报价延迟15分钟
275.38M总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
Springer Timothy A
29.41%
Seven One Eight Three Four Irrevocable Trust
15.50%
Squarepoint Capital LLP
7.52%
Fidelity Management & Research Company LLC
4.65%
Singer (Michael S.)
2.33%
其他
40.58%
持股股东
持股股东
占比
Springer Timothy A
29.41%
Seven One Eight Three Four Irrevocable Trust
15.50%
Squarepoint Capital LLP
7.52%
Fidelity Management & Research Company LLC
4.65%
Singer (Michael S.)
2.33%
其他
40.58%
股东类型
持股股东
占比
Individual Investor
36.03%
Corporation
17.74%
Investment Advisor
11.14%
Investment Advisor/Hedge Fund
10.75%
Hedge Fund
2.72%
Research Firm
0.52%
Bank and Trust
0.15%
Pension Fund
0.07%
Venture Capital
0.03%
其他
20.86%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
191
7.99M
27.21%
+636.40K
2025Q4
185
6.46M
24.83%
-1.21M
2025Q3
181
6.69M
25.71%
-763.38K
2025Q2
206
22.27M
85.81%
-1.28M
2025Q1
226
22.94M
90.08%
+138.68K
2024Q4
230
22.26M
88.90%
-105.22K
2024Q3
229
20.22M
92.77%
+6.58M
2024Q2
235
14.41M
85.20%
+9.02M
2024Q1
233
3.74M
346.71%
-1.42M
2023Q4
240
3.82M
71.00%
-922.87K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Springer Timothy A
8.64M
32.59%
+2.60K
+0.03%
Jan 02, 2026
Seven One Eight Three Four Irrevocable Trust
4.56M
17.18%
--
--
Apr 14, 2025
Squarepoint Capital LLP
2.21M
8.34%
+2.19M
+12032.00%
Mar 09, 2026
Fidelity Management & Research Company LLC
1.37M
5.16%
-788.79K
-36.59%
Dec 31, 2025
Singer (Michael S.)
683.10K
2.58%
-6.55K
-0.95%
Mar 13, 2026
TAS Partners, L.L.C.
656.51K
2.48%
+126.72K
+23.92%
Apr 14, 2025
BlackRock Institutional Trust Company, N.A.
554.24K
2.09%
-23.12K
-4.00%
Dec 31, 2025
Kalayoglu (Murat)
505.02K
1.91%
+2.60K
+0.52%
Jan 02, 2026
Lu (Chafen)
330.69K
1.25%
--
--
Apr 14, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Virtus LifeSci Biotech Clinical Trials ETF
0.54%
Invesco Nasdaq Biotechnology ETF
0.02%
ProShares Ultra Nasdaq Biotechnology
0.02%
iShares Micro-Cap ETF
0.02%
iShares Biotechnology ETF
0.01%
ALPS Medical Breakthroughs ETF
0%
Global X Russell 2000 ETF
0%
Invesco Russell 2000 Dynamic Multifactor ETF
0%
iShares Russell 2000 Value ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
Virtus LifeSci Biotech Clinical Trials ETF
占比0.54%
Invesco Nasdaq Biotechnology ETF
占比0.02%
ProShares Ultra Nasdaq Biotechnology
占比0.02%
iShares Micro-Cap ETF
占比0.02%
iShares Biotechnology ETF
占比0.01%
ALPS Medical Breakthroughs ETF
占比0%
Global X Russell 2000 ETF
占比0%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0%
iShares Russell 2000 Value ETF
占比0%
Proshares Ultra Russell 2000
占比0%